Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Shandong Weigao Group Medical Polymer Co ( (HK:1066) ).
Shandong Weigao Group Medical Polymer Co., Ltd. announced an overseas regulatory update, as per the disclosure requirements of the Hong Kong Stock Exchange. The announcement, published on the Shanghai Stock Exchange’s website, reflects the company’s compliance with regulatory standards, potentially impacting its market positioning and stakeholder confidence.
The most recent analyst rating on (HK:1066) stock is a Buy with a HK$7.50 price target. To see the full list of analyst forecasts on Shandong Weigao Group Medical Polymer Co stock, see the HK:1066 Stock Forecast page.
More about Shandong Weigao Group Medical Polymer Co
Shandong Weigao Group Medical Polymer Co., Ltd. is a company based in the People’s Republic of China, specializing in medical polymer products. The company operates in the healthcare industry, focusing on the development and manufacturing of medical devices and equipment.
Average Trading Volume: 12,326,945
Technical Sentiment Signal: Hold
Current Market Cap: HK$30.89B
See more insights into 1066 stock on TipRanks’ Stock Analysis page.